The ability of this BsAb to inhibit the migration of c-MET/PD-L1+ CRC cells and exhibit robust anti-tumor effects against HCT116 tumors in mice was demonstrated, possibly by inducing the degradation of c-MET protein in a dose and time-dependent manner (39). This evidence concerns the gene MET and colorectal carcinoma.